Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07324720Not ApplicableRecruiting

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

Role: lead

NCT06104033Recruiting

Practice Change With Drug-coated Balloon in Patients With multiVessel Coronary Artery Disease

Role: lead

NCT05672862Completed

International Post-PCI FFR Extended Registry

Role: lead

NCT04684043Unknown

Prognostic Implications of Physiologic Investigation After Revascularization With Stent

Role: lead

NCT03935542Completed

Assessment of Diagonal Branch Territory

Role: lead

All 5 trials loaded